Lobbying Costs Impede Biotech Venture Capitalism

Lobbying Costs Impede Biotech Venture Capitalism Play

Sept. 24 (Bloomberg) -- Bloomberg News' Shannon Pettypiece discusses the risk and uncertainty hindering biotech venture capitalism. She speaks with Deirdre Bolton on Bloomberg Television's "Money Moves." (Source: Bloomberg)

(enter your email)
(enter up to 5 email addresses, separated by commas)

Max 250 characters

blog comments powered by Disqus